DIMENSIONAL FUND ADVISORS LP - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$707,000
-57.4%
3,573,276
-3.0%
0.00%
-100.0%
Q3 2018$1,661,000
-23.0%
3,683,389
-14.0%
0.00%0.0%
Q2 2018$2,156,000
-77.8%
4,281,328
+2.7%
0.00%
-75.0%
Q1 2018$9,710,000
+43.4%
4,167,585
+74.8%
0.00%
+33.3%
Q4 2017$6,771,000
+174.7%
2,383,820
+176.6%
0.00%
+200.0%
Q3 2017$2,465,000
+19.9%
861,790
+3.6%
0.00%0.0%
Q2 2017$2,056,000
+15.6%
832,186
+69.0%
0.00%0.0%
Q1 2017$1,778,000
+437.2%
492,547
+426.4%
0.00%
Q4 2016$331,000
-1.5%
93,569
+12.5%
0.00%
Q3 2016$336,000
+253.7%
83,142
+284.9%
0.00%
Q2 2016$95,000
+58.3%
21,600
+36.6%
0.00%
Q1 2016$60,000
+445.5%
15,816
+2536.0%
0.00%
Q4 2014$11,000
-99.5%
600
-99.6%
0.00%
-100.0%
Q3 2014$2,143,000
-82.6%
165,385
-78.1%
0.00%
-77.8%
Q2 2014$12,329,000
-26.9%
755,433
-20.9%
0.01%
-30.8%
Q1 2014$16,874,000
-38.6%
954,784
-15.9%
0.01%
-38.1%
Q4 2013$27,483,000
-31.8%
1,135,258
-0.2%
0.02%
-40.0%
Q3 2013$40,299,000
+121.1%
1,137,412
-2.6%
0.04%
+105.9%
Q2 2013$18,223,0001,167,4290.02%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2016
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders